[ad_1]
In the United States of America there are 4 vaccines that are being verified and are in the third phase of clinical trials. Three of them belong to American companies, in addition to the British vaccine “Oxford – AstraZeneca”. The latter is still pending in the United States, as a volunteer within the United Kingdom was reported to have “unexplained” symptoms, according to “AstraZeneca,” while the New York Times quoted a source who declined to be named that the British volunteer had contracted an infection. In the spinal cord after receiving the vaccine. After several days, trials of the “AstraZeneca” vaccine resumed in the UK, India, and Brazil, but are still on hold in the US until now. With the Johnson & Johnson vaccine entering the comment space, two vaccines remain in operation in the United States: the modern vaccine and the Biontech and Pfizer vaccine, which entered the third phase of clinical trials on July 27. . It’s worth mentioning, here, that Dr. Maathai Mammen, who is the Johnson & Johnson Group’s Janssen Global Research and Development Officer, told investors in a conference call later Tuesday that “the company has very little information “, including This is whether the patient had received the real or fake vaccine, as quoted by the American network” CNBC “.
The treatment “elli”
It is unclear what happened in Eli Lilly’s experiment. A spokeswoman for the National Institutes of Health (NIH) said yesterday: “The trial, which included 326 Covid-19 patients, was temporarily halted after the Independent Safety Committee found that after five days of treatment, the group of patients who received the antibodies showed a clinical condition. Different from the placebo group, which was a difference that exceeded the preset safety threshold. “
Two out of every 4 vaccines and one treatment have been temporarily stopped in the United States.
And “Eli Lilly” is one of several US companies that are testing experimental treatments against “Covid-19”, using monoclonal antibodies that mimic immune molecules produced by the human body in response to the Corona virus. The company’s treatment is very similar to the Regeneron Company’s experimental treatment, which was received by the President of the United States shortly after entering Walter Reed Military Medical Center, which is a mixture of cloned antibodies from the antibodies in people who have recovered. of the “Covid-19”. It is injected into the patient intravenously, and its mission is to eliminate the virus responsible for the disease by attaching it to the “SARS-Cove-2” virus and preventing it from penetrating and entering human cells. In the wake of his discharge from the hospital, Trump said he would make Regeneron available to all Americans, especially after many of his supporters requested it. As a result, the companies “Eli Lilly” and “Regeneron”, last week, submitted an application to the “United States Food and Drug Administration” (FDA) for urgent approval of their treatments, at a time when the one that the “FDA” is verifying the safety of these two treatments and not causing them with serious side effects.
Vitamin D”
Researchers from Queen Mary University of London launched a new clinical trial to verify whether taking vitamin D could protect people from “Covid-19” and other respiratory diseases. The estimated number of volunteers for the test is 5,440 people, while the test will begin on October 19 and end on June 30, 2021. In this regard, the principal investigator, Professor Adrian Martineau of Queen Mary University, said : “There is growing evidence that vitamin D may reduce the risk of respiratory infections, as some recent studies indicate that people with low levels of vitamin D may be more susceptible to coronavirus infection.” He added that “vitamin D deficiency is more common in the elderly, overweight people, blacks, Asians, and all groups at risk of severe illness from Covid-19.” Martineau noted that “the UK government is already recommending that people take a low dose of vitamin D during winter to protect their bone health, but we don’t know if this will affect Covid-19 or if high doses can provide protection against Viruses. This trial will test whether high doses of vitamin D can provide protection against winter respiratory infections, including Covid-19. ” Trial volunteers will not be contacted directly, but vitamin D doses will be mailed to them.
Curfew in France
Starting Saturday, France will impose a nightly curfew (between 9 p.m. and 6 a.m.) in several major cities, including Paris, with the aim of tackling the second epidemic wave, as announced by French President Emmanuel Macron. Yesterday, he confirmed that the aforementioned measure “will continue for four weeks, and we will go to Parliament to extend it until December 1”. Six weeks is a period that seems feasible to us ”. In addition to Paris and its region, the measure includes eight main cities: Lille, Lyon, Aix-Marseille, Grenoble, Montpellier, Saint-Etienne, Rouen and Toulouse. In practice, the decision means closing restaurants, bars, theaters and cinemas, without including restrictions on movement in the country.
(AFP)
Subscribe to «News» on YouTube here
